No Data
No Data
Mizuho Securities Maintains Sage Therapeutics(SAGE.US) With Hold Rating, Maintains Target Price $9
TD Cowen Maintains Sage Therapeutics(SAGE.US) With Hold Rating, Maintains Target Price $9
Cautious Hold Rating on SAGE Therapeutics Amid Financial Pressures and Strategic Uncertainties
SAGE Therapeutics (SAGE) Gets a Hold From Mizuho Securities
Earnings Call Summary | Sage Therapeutics(SAGE.US) Q1 2025 Earnings Conference
SAGE THERAPEUTICS Earnings Results: $SAGE Reports Quarterly Earnings
Newbee4 : $Bridger Aerospace (BAER.US)$